Heron Enterprise Value Over E B I T D A from 2010 to 2024
| HRTX Stock | USD 1.19 0.03 2.59% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (3.72) | Current Value (3.90) | Quarterly Volatility 3.37879446 |
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 110. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
Heron | Enterprise Value Over E B I T D A |
Latest Heron Therapeuti's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Heron Therapeuti over the last few years. It is Heron Therapeuti's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Heron Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (5.20) | |
| Coefficient Of Variation | (64.91) | |
| Mean Deviation | 2.88 | |
| Median | (3.90) | |
| Standard Deviation | 3.38 | |
| Sample Variance | 11.42 | |
| Range | 10.0265 | |
| R-Value | (0) | |
| Mean Square Error | 12.29 | |
| R-Squared | 0.000024 | |
| Significance | 0.99 | |
| Slope | (0) | |
| Total Sum of Squares | 159.83 |
Heron Enterprise Value Over E B I T D A History
About Heron Therapeuti Financial Statements
Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (3.72) | (3.90) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.